文献速递肿瘤 PET/CT

FDG PET用于霍奇金和非霍奇金淋巴瘤的治疗监测

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-04-14

本文综述了18F-FDG PET在淋巴瘤治疗监测中的应用。PET/CT目前用于治疗期间评估化疗敏感性,在成人和儿童霍奇金淋巴瘤临床实践中根据中期PET进行反应指导治疗。国际指南推荐使用Deauville五分法(含Deauville标准)进行反应评估,FDG摄取参照正常纵隔和肝脏区域分级。Deauville标准已在大多数淋巴瘤亚型中验证,并允许根据临床背景或研究问题调整充分或不充分反应的阈值。标准化定量方法(包括qPET)也已开发,可能进一步改善反应评估。

要点

  • 国际指南推荐Deauville五分法用于淋巴瘤反应评估,FDG摄取参照正常纵隔和肝脏分级。
  • PET/CT用于治疗期间评估化疗敏感性,成人及儿童霍奇金淋巴瘤按中期PET行反应指导治疗。
  • Deauville标准已在多数淋巴瘤亚型中验证,阈值可随临床背景或研究问题调整。

核心结论

  • 18F-FDG PET是淋巴瘤治疗监测中发展最成熟的临床应用之一,国际指南推荐Deauville五分法用于反应评估。
  • 定量方法(包括qPET)可能进一步改善反应评估,提供连续尺度以细化阈值并减少观察者依赖。

研究设计与样本

  • 综述,检索范围未明确报告。

主要发现

  • PET/CT目前用于治疗期间评估化疗敏感性,成人和儿童霍奇金淋巴瘤临床实践中根据中期PET进行反应指导治疗。
  • PET也用于评估疾病缓解和移植前预后预测。
  • 侵袭性B细胞淋巴瘤常见亚型已有成熟数据,较新数据也支持PET用于T细胞淋巴瘤的反应评估。
  • Deauville标准已在大多数淋巴瘤亚型中验证,FDG摄取参照正常纵隔和肝脏区域分级。
  • 定量方法(包括qPET)已开发,可能提供连续尺度以细化特定临床情况或试验中治疗优化的充分或不充分反应阈值,且较少依赖观察者并限制背景活性影响所致的光学误判问题。

关键数值与推荐

  • 国际指南推荐Deauville五分法(含Deauville标准)用于反应评估。
  • Deauville标准允许根据临床背景或研究问题调整充分或不充分反应的阈值。
  • PET阅读者需理解Deauville标准在反应指导试验中的应用方式,以便正确解读并与多学科团队讨论。

临床怎么用

  • 成人及儿童霍奇金淋巴瘤临床实践中根据中期PET进行反应指导治疗。
  • PET用于评估疾病缓解和移植前预后预测。
  • 国际指南推荐Deauville五分法用于反应评估,FDG摄取参照正常纵隔和肝脏区域分级。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PET using 18F-FDG for treatment monitoring in patients with lymphoma is one of the most well-developed clinical applications. PET/CT is nowadays used during treatment to assess chemosensitivity, with response-adapted therapy given according to 'interim' PET in clinical practice to adults and children with Hodgkin lymphoma. PET is also used to assess remission from disease and to predict prognosis in the pretransplant setting. Mature data have been reported for the common subtypes of aggressive B-cell lymphomas, with more recent data also supporting the use of PET for response assessment in T-cell lymphomas. The Deauville five-point scale incorporating the Deauville criteria (DC) is recommended for response assessment in international guidelines. FDG uptake is graded in relation to the reference regions of normal mediastinum and liver. The DC have been validated in most lymphoma subtypes. The DC permit the threshold for adequate or inadequate response to be adapted according to the clinical context or research question. It is important for PET readers to understand how the DC have been applied in response-adapted trials for correct interpretation and discussion with the multidisciplinary team. Quantitative methods to perform PET in standardized ways have also been developed which may further improve response assessment including a quantitative extension to the DC (qPET). This may have advantages in providing a continuous scale to refine the threshold for adequate/inadequate response in specific clinical situations or treatment optimization in trials. qPET is also less observer-dependent and limits the problem of optical misinterpretation due to the influence of background activity.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Barrington SF, Kluge R. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging. 2017. PMID: 28411336. doi:10.1007/s00259-017-3690-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。